NDC 49288-0054
Blackberry
Blackberry
Blackberry is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Blackberry.
| Product ID | 49288-0054_1d11d7ba-8b48-401c-a02e-42b54abb4296 |
| NDC | 49288-0054 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Blackberry |
| Generic Name | Blackberry |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1974-03-23 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102223 |
| Labeler Name | Antigen Laboratories, Inc. |
| Substance Name | BLACKBERRY |
| Active Ingredient Strength | 0 g/mL |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 49288-0054-3
10 mL in 1 VIAL, MULTI-DOSE (49288-0054-3)
| Marketing Start Date | 1974-03-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 49288-0054-2 [49288005402]
Blackberry INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0054-4 [49288005404]
Blackberry INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0054-5 [49288005405]
Blackberry INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0054-1 [49288005401]
Blackberry INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
NDC 49288-0054-3 [49288005403]
Blackberry INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| BLACKBERRY | .05 g/mL |
OpenFDA Data
NDC Crossover Matching brand name "Blackberry" or generic name "Blackberry"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 36987-1298 | Blackberry | Blackberry |
| 36987-1299 | Blackberry | Blackberry |
| 36987-1300 | Blackberry | Blackberry |
| 36987-1301 | Blackberry | Blackberry |
| 49288-0054 | Blackberry | Blackberry |
| 54575-353 | BLACKBERRY | blackberry |
Trademark Results [Blackberry]
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.